BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 27, 2008
View Archived Issues
FTY-720 associated with viral clearance in models of infection
Read More
TRPM8 antagonism may attenuate hypersensitivity to cold
Read More
NP-12 reduces tau and beta-amyloid pathology in mice
Read More
Recent patents report novel treatment options for endocrine disorders
Read More
Novel Rac1/Rac1b inhibitors prevent Abeta production, display improved metabolic stability
Read More
Animal model of siRNA therapy for HIV infection created
Read More
FG-4497 shows promise in rat kidney transplant model
Read More
EP-1013 enhances effects of costimulation blockade for islet transplantation
Read More
Pfizer unveils potent and selective c-Met inhibitor PF-4254644
Read More
New analgesic agents disclosed in recent patent literature
Read More
Recent Roche patent describes new treatments for depression, anxiety
Read More
Otsuka acquires Interpharma Praha from Interpharma West
Read More
AVEO initiates phase Ib combination trial of AV-951 and FOLFOX-6
Read More
Avexa and Shire renegotiate apricitabine license agreement
Read More
Biofrontera and DSE form license agreement for U.S. Relieva distribution
Read More
Galapagos acquires Sareum Holdings' structure-based drug discovery services
Read More
Genzyme and Medicines for Malaria Venture collaborate with Advinus
Read More
Novosom acquires exclusive license for Isis' CD40-targeted antisense inhibitors
Read More
Phase II IMC-A12 and IMC-1121B trial enrolls advanced prostate cancer patients
Read More
Zostavax approved in Canada for the prevention of shingles
Read More
Ark commences patient enrollment in phase III Vitor pilot study in cachexia
Read More
Curis doses first patient in phase I CUDC-101 trial
Read More
FDA fast tracks droxidopa for symptomatic neurogenic orthostatic hypotension
Read More
FDA grants Glivec priority review for gastrointestinal stromal tumors
Read More
FDA issues complete response letter for paliperidone palmitate for schizophrenia
Read More